sufentanil has been researched along with sb 216763 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, YY; Chen, QL; Fang, WP; Gu, EW; Zhang, L; Zhu, Y | 1 |
1 other study(ies) available for sufentanil and sb 216763
Article | Year |
---|---|
Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β.
Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Heart Rate; Indoles; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sufentanil; Troponin I | 2013 |